We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$43.8B
AUM Growth
+$1B
Cap. Flow
-$59.5M
Cap. Flow %
-0.14%
Top 10 Hldgs %
14.97%
Holding
3,057
New
207
Increased
1,365
Reduced
1,344
Closed
128

Sector Composition

Rank Sector Weight
1 Financials 16.4%
2 Technology 15.29%
3 Healthcare 13.69%
4 Industrials 10.84%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PACB icon
2451
Pacific Biosciences
PACB
$435M
$372K ﹤0.01%
104,614
+2,650
+3% +$10.7K
WNEB icon
2452
Western New England Bancorp
WNEB
$260M
$372K ﹤0.01%
36,620
+11,545
+46% +$119K
AMNB
2453
DELISTED
American National Bankshares Inc
AMNB
$372K ﹤0.01%
10,070
-1,305
-11% -$48.2K
MCFT icon
2454
MasterCraft Boat Holdings
MCFT
$596M
$371K ﹤0.01%
+18,980
New +$340K
STRL icon
2455
Sterling Infrastructure
STRL
$15.2B
$371K ﹤0.01%
+28,360
New +$289K
FMBH icon
2456
First Mid Bancshares
FMBH
$1.4B
$370K ﹤0.01%
+10,803
New +$367K
AOSL icon
2457
Alpha and Omega Semiconductor
AOSL
$829M
$368K ﹤0.01%
22,076
-2,260
-9% -$40.1K
TTPH
2458
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$368K ﹤0.01%
2,582
+139
+6% +$21.5K
NVEE
2459
DELISTED
NV5 Global
NVEE
$367K ﹤0.01%
34,524
+3,480
+11% +$33.6K
GEOS icon
2460
Geospace Technologies
GEOS
$84M
$366K ﹤0.01%
26,443
+630
+2% +$9.68K
CLDX icon
2461
Celldex Therapeutics
CLDX
$2.94B
$365K ﹤0.01%
9,844
-303
-3% -$13.4K
SRGA
2462
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$363K ﹤0.01%
2,067
-254
-11% -$36.1K
CRMT icon
2463
America's Car Mart
CRMT
$25.9M
$362K ﹤0.01%
9,295
-1,280
-12% -$47.2K
EMWP
2464
DELISTED
Eros Media World PLC
EMWP
$360K ﹤0.01%
1,570
-224
-12% -$45.8K
ZIXI
2465
DELISTED
Zix Corporation
ZIXI
$360K ﹤0.01%
63,210
-4,078
-6% -$22.9K
BATRA icon
2466
Atlanta Braves Holdings Series A
BATRA
$3.51B
$359K ﹤0.01%
15,009
+801
+6% +$19.3K
ARTNA icon
2467
Artesian Resources
ARTNA
$360M
$358K ﹤0.01%
9,520
-835
-8% -$31.3K
BLCM
2468
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$358K ﹤0.01%
3,067
+725
+31% +$90K
AUD
2469
DELISTED
Audacy, Inc.
AUD
$358K ﹤0.01%
34,558
+1,047
+3% +$11.8K
BSRR icon
2470
Sierra Bancorp
BSRR
$532M
$356K ﹤0.01%
14,521
-300
-2% -$7.63K
WFBI
2471
DELISTED
WashingtonFirst Bankshares Inc
WFBI
$356K ﹤0.01%
+10,314
New +$318K
FPI
2472
Farmland Partners
FPI
$415M
$355K ﹤0.01%
39,709
+14,205
+56% +$144K
CSS
2473
DELISTED
CSS Industries, Inc.
CSS
$355K ﹤0.01%
13,552
-1,415
-9% -$37.2K
OPCH icon
2474
Option Care Health
OPCH
$3.76B
$353K ﹤0.01%
32,531
+2,747
+9% +$20.9K
CUTR
2475
DELISTED
Cutera, Inc.
CUTR
$353K ﹤0.01%
13,615
-25
-0.2% -$546

Similar funds

RhumbLine Advisers's Q2 2017 Portfolio in Review

As of Q2 2017, RhumbLine Advisers held 3,057 positions worth $43.8B, up 2.3% from $42.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers's Q2 2017 filing shows 207 new, 1,365 increased, 1,344 reduced and 128 closed positions. Its largest new stake was DXC Technology: 615,360 shares worth $40.8M. The largest sale was Yahoo Inc, an estimated $68.4M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q2 2017 buy was DXC Technology: 615,360 shares worth $40.8M.
  • RhumbLine Advisers added most to IHS Markit Ltd. Common Shares in Q2 2017, an estimated $26.7M increase.
  • RhumbLine Advisers's biggest Q2 2017 reduction was Apple, cutting an estimated $23.6M.
  • RhumbLine Advisers fully exited Yahoo Inc in Q2 2017, selling an estimated $68.4M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $43.8B portfolio in Q2 2017.
  • RhumbLine Advisers opened 207 new positions and closed 128 in Q2 2017.
  • RhumbLine Advisers's portfolio value rose 2.3% quarter-over-quarter to $43.8B.

Based on RhumbLine Advisers's 13F filing for Q2 2017, filed 2 Aug 2017.